A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD
Recruiting
N/A
Interventional Study
IgG4-Related Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 46 (estimated)
- Sponsor
- Luo Yaping · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study intends to use the new technology of fibroblast activation protein PET / CT to study whether the tiny residual lesions detected by 68Ga-FAPI PET / CT are related to the recurrence of IgG4-RD in patients with IgG4-RD who have been clinically evaluated for complete remission after treatment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. age 18-75 years old ;
2. Meet the 2019 ACR / EURLAR IgG4-RD diagnostic criteria ;
3. The disease was stable for more than 1 year, and the clinical evaluation of the disease was complete remission \* ;
4. Glucocorticoid dosage ≤ prednisone 7.5mg / d × 6 months or more, or comb…
Contacts